AstraZeneca will this week unveil the design plans for its new Cambridge hub, which formed a key plank in its defence against US predator Pfizer.
The Anglo-Swedish drug maker is to launch a public consultation on the architectural plans for the new £330m facility on Friday.
Cambridge will become AstraZeneca’s global headquarters by the end of 2016, housing the company’s British research base as well as the staff from its current corporate base in London.
Help employers find you! Check out all the jobs and post your resume.
